phase readout
saveNCT06567860: Characterizing Late-season Influenza Vaccine Responses to Compare the 2023 and 2024 Vaccine Formulations
COMPLETEDupdated 7d ago
community read0 votes
Sponsor: La Jolla Institute for Immunology. Phase: PHASE4. Conditions: Influenza A
view source ↗
comments(0)
5-min edit window · permanent after that